10X Health Advances Precision Nutrition Platform, Expanding Internationally Through M42 Partnership in Abu Dhabi
核心洞察
Brandon Dawson, Chairman and CEO of 10X Health (搜索), is positioning precision nutrition as the next evolution of healthcare, moving beyond generalized population-level recommendations toward individualized biological understanding.
The 10X REVIV Precision Nutrition System integrates genetic analysis, blood biomarkers, and mitochondrial function to identify biological patterns linked to more than 110 symptoms, diseases, and disorders.
10X Health (搜索) has expanded internationally through a partnership with M42 (搜索) in Abu Dhabi, which Dawson describes as one of the world's most advanced precision health platforms.
For more than a century, healthcare has largely operated according to a single model: a patient becomes unwell, symptoms appear, a diagnosis is made, and treatment begins. Brandon Dawson, Chairman and CEO of 10X Health (搜索), argues that this approach was never designed for the healthcare challenges of the future. "The healthcare model is changing," Dawson says. "For generations we've relied on generalized recommendations designed for large populations. The future belongs to understanding the biology of the individual."
At the center of Dawson's vision is the 10X REVIV Precision Nutrition System, developed through more than twelve years of proprietary life sciences research. The patented platform combines advanced genetic analysis, blood biomarkers, mitochondrial function, and other key biological indicators through proprietary methodologies built from biological mapping across forty-seven countries.
The objective, according to the company, is not simply to generate another genetic report, but to transform biological complexity into practical, personalized decisions that individuals and healthcare professionals can actually use. "Data alone doesn't change lives," Dawson has said in discussions around precision health. "Understanding what that data actually means."
From Data Collection to Biological Interpretation
Over the past decade, genetic testing has become increasingly accessible, and millions of people can now access information about their DNA. Dawson believes the challenge has shifted from collecting biological information to interpreting it with greater precision. Without appropriate interpretation, he argues, biological data may offer limited practical context.
The company's proprietary life sciences platform is designed to identify DNA variants, mutations, nutrient deficiencies, and biological patterns that may contribute to more than 110 symptoms, diseases, and disorders, before translating those insights into highly individualized precision nutrition protocols. Every protocol begins with one principle: no two biological systems are identical.
Dawson illustrates this with a recurring example. Two individuals can consume identical diets, follow the same exercise program, and take the same nutritional supplements while experiencing entirely different outcomes, because their bodies process nutrients, regulate metabolism, respond to inflammation, and recover from physical stress differently.
A Broader Precision Health Ecosystem
The precision nutrition philosophy extends throughout the broader 10X Health (搜索) ecosystem. Depending on a person's biological profile and clinical assessment, that ecosystem may include precision-formulated supplementation, advanced blood biomarker analysis, peptide therapies where clinically appropriate, IV nutrient therapies, wellness assessments, and ongoing health optimization programs. Each component is designed to complement the others rather than operate in isolation.
For Dawson, precision health is not about selling individual products. It is about building a complete biological understanding of the individual before making recommendations. Precision-formulated supplementation is guided by an individual's biological profile rather than generalized nutritional assumptions, and peptide therapies are incorporated, where clinically appropriate, as one component within a broader precision health strategy.
International Expansion and the M42 Partnership
Dawson's vision for precision health has never been limited to the United States. From the beginning, he believed the future of personalized healthcare would depend on global collaboration between scientists, clinicians, researchers, governments, and technology leaders. That vision led to the international expansion of the 10X REVIV Precision Nutrition System through a partnership with REVIV Global (搜索), bringing the platform to markets beyond the United States.
One of the most significant milestones in that journey was Abu Dhabi. Rather than selecting a market based solely on commercial opportunity, Dawson intentionally chose to partner with M42 (搜索), recognizing Abu Dhabi's growing position as a leading center for healthcare innovation, genomics, life sciences, and longevity research.
"We chose Abu Dhabi very intentionally," Dawson says. "M42 (搜索) represents one of the world's most advanced precision health platforms because of its commitment to improving population health through science, innovation, and long-term investment. Their leadership is tackling some of the world's largest and most complex healthcare challenges while helping build a truly evidence-based approach to longevity."
He continues: "When you have leadership willing to invest in the future of human health, attract the brightest scientific minds from around the world, and build global collaborations that push medicine forward, you know that's where you need to be. That's exactly what we found in Abu Dhabi."
An Evolution, Not a Replacement
Around the world, healthcare systems continue to face rising rates of chronic disease, aging populations, and increasing demand for more personalized care. Dawson believes precision nutrition offers an opportunity to move beyond generalized recommendations by helping individuals better understand their own biology before making important decisions about nutrition, recovery, performance, and long-term wellbeing.
He is careful not to position precision nutrition as a replacement for traditional medicine. Instead, he sees it as an evolution, one that equips healthcare professionals and individuals with deeper biological intelligence so decisions can become more informed, more personalized, and ultimately more precise.
If the last century of healthcare was built around treating populations, Dawson believes the next will be built around understanding individuals. As he frames it, the future of healthcare will not belong to those who collect the most biological data, but to those who understand biology with the greatest precision and use that understanding to improve human health.
This article is for informational purposes only and does not substitute for professional medical advice. These statements have not been evaluated by the Food and Drug Administration, and the product is not intended to diagnose, treat, cure, or prevent any disease.
